Başcı, S. Et Al. 2022. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Internal and Emergency Medicine , vol.17, no.1 , 135-139.

Başcı, S., Ata, N., ALTUNTAŞ, F., Yiğenoğlu, T. N., Dal, M. S., Korkmaz, S., ... Namdaroğlu, S.(2022). Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Internal and Emergency Medicine , vol.17, no.1, 135-139.

Başcı, SEMİH Et Al. "Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers," Internal and Emergency Medicine , vol.17, no.1, 135-139, 2022

Başcı, SEMİH Et Al. "Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers." Internal and Emergency Medicine , vol.17, no.1, pp.135-139, 2022

Başcı, S. Et Al. (2022) . "Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers." Internal and Emergency Medicine , vol.17, no.1, pp.135-139.

@article{article, author={SEMİH BAŞCI Et Al. }, title={Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers}, journal={Internal and Emergency Medicine}, year=2022, pages={135-139} }